Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (111-120 of 286) with videos related to

Pageof 29
Sort By:
Endocrine-Related Cancer|September 10, 2011
mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancerMatthew J Schiewer, Robert Den, David T Hoang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2013
The responsibilities of a chief resident in radiation oncology: results of a national surveyNicholas G Zaorsky, Joshua Siglin, Robert B Den, et al.
American Journal of Clinical Oncology|March 26, 2016
Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and ToxicitiesNicholas G Zaorsky, Scott W Keith, Talha Shaikh, et al.
Ultrasound in Medicine & Biology|June 7, 2002
Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary resultsFlemming Forsberg, Adam P Dicker, Mattew L Thakur, et al.
American Journal of Cancer Research|December 19, 2014
Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung cancer cells in vitroNingbo Liu, Zhen Tao, Justin M Le Blanc, et al.
Cancer Growth and Metastasis|March 20, 2018
The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation SchedulesKimberly M Arnold, Nicole J Flynn, Adam Raben, et al.
Future Oncology (London, England)|July 11, 2013
Selectively starving cancer cells through dietary manipulation: methods and clinical implicationsBrittany A Simone, Colin E Champ, Anne L Rosenberg, et al.
American Journal of Clinical Oncology|June 21, 2016
The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate CancerNicholas G Zaorsky, Brian L Egleston, Eric M Horwitz, et al.
American Journal of Clinical Oncology|July 9, 2016
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck CancerPeter H Ahn, Mitchell Machtay, Pramila R Anne, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2012
Implanted dosimeters identify radiation overdoses during IMRT for prostate cancerRobert B Den, Kamila Nowak, Ivan Buzurovic, et al.
Pageof 29

Showing results (111-120 of 286) with videos related to

Sort By:
Pageof 29
Endocrine-Related Cancer|September 10, 2011
mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancerMatthew J Schiewer, Robert Den, David T Hoang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2013
The responsibilities of a chief resident in radiation oncology: results of a national surveyNicholas G Zaorsky, Joshua Siglin, Robert B Den, et al.
American Journal of Clinical Oncology|March 26, 2016
Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and ToxicitiesNicholas G Zaorsky, Scott W Keith, Talha Shaikh, et al.
Ultrasound in Medicine & Biology|June 7, 2002
Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary resultsFlemming Forsberg, Adam P Dicker, Mattew L Thakur, et al.
American Journal of Cancer Research|December 19, 2014
Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung cancer cells in vitroNingbo Liu, Zhen Tao, Justin M Le Blanc, et al.
Cancer Growth and Metastasis|March 20, 2018
The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation SchedulesKimberly M Arnold, Nicole J Flynn, Adam Raben, et al.
Future Oncology (London, England)|July 11, 2013
Selectively starving cancer cells through dietary manipulation: methods and clinical implicationsBrittany A Simone, Colin E Champ, Anne L Rosenberg, et al.
American Journal of Clinical Oncology|June 21, 2016
The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate CancerNicholas G Zaorsky, Brian L Egleston, Eric M Horwitz, et al.
American Journal of Clinical Oncology|July 9, 2016
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck CancerPeter H Ahn, Mitchell Machtay, Pramila R Anne, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2012
Implanted dosimeters identify radiation overdoses during IMRT for prostate cancerRobert B Den, Kamila Nowak, Ivan Buzurovic, et al.
Pageof 29